Trial Profile
Effectiveness of a combined Vi vaccination and health education program on reducing the burden of typhoid during childhood: A demonstration project in Karachi
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2023
Price :
$35
*
At a glance
- Drugs Typhoid vaccine Vi-polysaccharide (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A; Typhoid
- Focus Therapeutic Use
- 26 Jan 2010 Patient numbers amended from 12830 to 27231, additional lead trial centre as reported by ClinicalTrials.gov.
- 12 Mar 2008 Status changed from in progress to completed. Updated from ClinicalTrials.gov.
- 14 Dec 2005 New trial record.